UK cancer mutation testing firm Biofidelity raises $12mCambridge, UK-based Biofidelity has raised $12 million in first-round funding for its cancer diagnosis platform, which can detect Share XUK cancer mutation testing firm Biofidelity raises $12mhttps://pharmaphorum.com/news/uk-cancer-mutation-testing-firm-biofidelity-raises-12m/
In-vitro Diagnostics Market profiled Qiagen, Becton Dickinson, Grifols & BioMerieux by 2025In-vitro Diagnostics Market will reach $95bn by 2025 Share XIn-vitro Diagnostics Market profiled Qiagen, Becton Dickinson, Grifols & BioMerieux by 2025https://pharmaphorum.com/partner-content/in-vitro-diagnostics-market-profiled-qiagen-becton-dickinson-grifols-biomerieux-by-2025/